Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1098 A 3D tumor-stroma-immune co-culture platform for bispecific antibody screening in pancreatic ductal adenocarcinoma

  1. 11Garvan Institute of Medical Research, Sydney, NSW, Australia
  2. 2Inventia Life Science, Alexandria, NSW, Australia
  3. 3Australian Centre of NanoMedicine, UNSW Sydney, Sydney, NSW, Australia

Related

  1. Long-Term Drug Screening Identifies PARP Inhibitors as Irinotecan Combination Partners in BRCA1/2-Wild-Type Pancreatic Ductal Adenocarcinoma.
    Hyeweon Jang, Hansol Jang, Hye Yeon Yun +2
    Pharmaceuticals (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  2. Stuck in traffic: a bispecific antibody-mediated immune re-engagement after allogeneic stem cell transplantation
    Stephanie Boisclair, Monica Wallin, Sally Ko +1
    HaematologicaPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  3. 1187 Safety and efficacy of cesalatamig, a novel PD-1/VEGF bispecific antibody, as monotherapy in PD-(L)1–resistant/refractory NSCLC: Results from global, multicenter, open-label phase 1/2 studies
    Yang Liu, Yu Liu, Fawzi Abu Rous +31
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer
    HARMONi-A Study Investigators, Wenfeng Fang, Yuanyuan Zhao +68
    JAMAPeer-reviewedLicence not stated12 citedGeneral medicineOpenAlex
  5. From Dual Targeting to Clinical Validation: A Translational Framework for Bispecific Antibody–Drug Conjugates
    Jun Kim, Seounghun Kang
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMC
BibTeX
@article{porazinski20261098,
  title = {{1098 A 3D tumor-stroma-immune co-culture platform for bispecific antibody screening in pancreatic ductal adenocarcinoma}},
  author = {Sean Porazinski and Morgan Hamon and Matthieu Spriet and Susan Harrison Uy and Peilin Tian and Christine Yee},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1098},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1098},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1098 A 3D tumor-stroma-immune co-culture platform for bispecific antibody screening in pancreatic ductal adenocarcinoma
AU  - Sean Porazinski
AU  - Morgan Hamon
AU  - Matthieu Spriet
AU  - Susan Harrison Uy
AU  - Peilin Tian
AU  - Christine Yee
PY  - 2026
DA  - 2026/11/08
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1098
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1098
SN  - 2051-1426
ER  -